Biofidelity, the UK start-up about to revolutionise amplification-based cancer diagnostics

SOPHIA-ANTIPOLIS, France – August 31, 2020 | Biofidelity recently announced that it has raised $12 million, completing its Series A financing. The company disclosed that the series A investors are BlueYard Capital, Longwall Ventures and Agilent Technologies. Biofidelity is, above all, focused on developing non-small cell lung cancer detection assays that surpass the performance of[…]

Microneedle patch in the race for COVID-19 vaccine

SOPHIA-ANTIPOLIS, France – August 24, 2020 | The race to find a COVID-19 vaccine has highlighted several microneedle technologies for their advantages over common parenteral injections. Microneedles have shown immense potential, since they can efficiently, painlessly and safely deliver a vaccine through the skin. Microneedles reach the underlying dermis and epidermis, rich in antigen presenting[…]

Allos Semiconductors moving away from power electronics and transferring its patents & know-how to a new entrant in GaN-on-Si technology

SOPHIA-ANTIPOLIS, France – July 22, 2020 | On July 8th, 2020, Allos Semiconductors disclosed a deal with Azur Space, a company specializing in the development and production of multi-junction solar cells, to sell its GaN RF and power electronics business, in a view to focus on its GaN-on-Si micro LED epiwafer technology for up to[…]

Why does II-VI rely on General Electric’s IP to conquer the power SiC markets?

SOPHIA-ANTIPOLIS, France – July 07, 2020 | As announced earlier this month, optical component and materials maker II-VI has licensed Silicon Carbide (SiC) technology from General Electric with a view to move into power devices and modules. Just like Cree/Wolfspeed and Rohm Group Company (including SiCrystal), the main competitors of II-VI on the SiC wafer market,[…]